Answers are grounded in this paper and cite their sources.
Tezepelumab resulted in clinically meaningful improvements in sino-nasal symptoms and asthma outcomes in patients with severe asthma with comorbid NPs.
No takes yet. Share an insight, caveat, or question.
Laidlaw et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: